SGA
Sector Gamma AS Portfolio holdings
AUM
$306M
This Quarter Return
+9.41%
1 Year Return
+4.68%
3 Year Return
+19.67%
5 Year Return
+46.47%
10 Year Return
+161.43%
AUM
$371M
AUM Growth
+$371M
(-4.9%)
Cap. Flow
-$57.1M
Cap. Flow
% of AUM
-15.41%
Top 10 Holdings %
Top 10 Hldgs %
58.29%
Holding
41
New
8
Increased
14
Reduced
10
Closed
8
Top Buys
| 1 |
Quest Diagnostics
DGX
|
$8.2M |
| 2 |
ResMed
RMD
|
$7.11M |
| 3 |
STJ
St Jude Medical
STJ
|
$6.57M |
| 4 |
Biogen
BIIB
|
$5.59M |
| 5 |
HNT
HEALTH NET INC
HNT
|
$4.3M |
Top Sells
| 1 |
FRX
FOREST LABORATORIES INC
FRX
|
$21.9M |
| 2 |
Johnson & Johnson
JNJ
|
$14.5M |
| 3 |
ONXX
ONYX PHARMACEUTICALS INC
ONXX
|
$12.9M |
| 4 |
WCG
Wellcare Health Plans, Inc.
WCG
|
$10.4M |
| 5 |
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
|
$9.45M |
Sector Composition
| 1 | Healthcare | 88.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Eli Lilly
LLY
$657B
| $41.1M | 11.08% | 804,947 +80,600 | +11% | +$4.11M |
|
2
Boston Scientific
BSX
$156B
| $31.2M | 8.41% | 2,594,800 +43,000 | +2% | +$517K |
|
|
FRX
3
DELISTED
FOREST LABORATORIES INC
FRX
| $26.4M | 7.13% | 440,349 -365,351 | -45% | -$21.9M |
|
4
Baxter International
BAX
$12.7B
| $24.2M | 6.52% | 347,600 +43,200 | +14% | +$3M |
|
5
Cardinal Health
CAH
$35.5B
| $19.8M | 5.33% | 295,700 -96,100 | -25% | -$6.42M |
|
|
6
Johnson & Johnson
JNJ
$427B
| $18.9M | 5.1% | 206,550 -158,250 | -43% | -$14.5M |
|
7
Agilent Technologies
A
$35.7B
| $16.2M | 4.37% | 283,000 +5,500 | +2% | +$315K |
|
8
Edwards Lifesciences
EW
$47.8B
| $14.3M | 3.85% | 217,000 +37,000 | +21% | +$2.43M |
|
|
CBST
9
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
| $12.1M | 3.27% | 176,090 -27,952 | -14% | -$1.93M |
|
10
Teva Pharmaceuticals
TEVA
$21.1B
| $11.9M | 3.22% | 297,700 +34,400 | +13% | +$1.38M |
|
11
Revvity
RVTY
$10.5B
| $11.7M | 3.15% | 283,160 +19,460 | +7% | +$802K |
|
|
LPNT
12
DELISTED
LifePoint Health, Inc.
LPNT
| $11.4M | 3.08% | 216,000 +28,600 | +15% | +$1.51M |
|
|
MDCO
13
DELISTED
Medicines Co
MDCO
| $11.1M | 3% | 287,850 -30,500 | -10% | -$1.18M |
|
14
UnitedHealth
UNH
$281B
| $10.7M | 2.88% | 141,700 +56,700 | +67% | +$4.27M |
|
|
ESRX
15
DELISTED
Express Scripts Holding Company
ESRX
| $10.3M | 2.78% | 146,800 +24,300 | +20% | +$1.71M |
|
|
THOR
16
DELISTED
THORATEC CORPORATION
THOR
| $9.89M | 2.67% | 270,100 +40,100 | +17% | +$1.47M |
|
|
AUXL
17
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
| $9.59M | 2.59% | 462,504 -299,420 | -39% | -$6.21M |
|
18
Ironwood Pharmaceuticals
IRWD
$214M
| $8.62M | 2.32% | 741,991 +319,000 | +75% | +$3.7M |
|
|
19
Quest Diagnostics
DGX
$20.3B
| $8.2M | 2.21% | +153,128 | New | +$8.2M |
|
20
Bio-Rad Laboratories Class A
BIO
$8.06B
| $7.19M | 1.94% | 58,200 +4,400 | +8% | +$544K |
|
|
21
ResMed
RMD
$40.2B
| $7.11M | 1.92% | +151,000 | New | +$7.11M |
|
22
Masimo
MASI
$7.59B
| $7.11M | 1.92% | 243,150 -132,541 | -35% | -$3.87M |
|
|
STJ
23
DELISTED
St Jude Medical
STJ
| $6.57M | 1.77% | +106,000 | New | +$6.57M |
|
|
24
Biogen
BIIB
$19.4B
| $5.59M | 1.51% | +20,000 | New | +$5.59M |
|
|
AGN
25
DELISTED
ALLERGAN INC
AGN
| $5M | 1.35% | 45,000 -22,900 | -34% | -$2.54M |
|